Title Page / Table of Contents.
- Published in:
- 2008
- Publication type:
- Table of Contents
Works matching IS 16602854 AND DT 2008 AND VI 5 AND IP 1
Results: 10
1
2
Therapeutic Antibodies in Multiple Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2008, v. 5, n. 1, p. 5, doi. 10.1159/000109931
- By:
- Publication type:
- Article
3
Intravenous Polyclonal Human Immunoglobulins in Multiple Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2008, v. 5, n. 1, p. 8, doi. 10.1159/000109932
- By:
- Publication type:
- Article
4
Natalizumab: Targeting α<sub>4</sub>-Integrins in Multiple Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2008, v. 5, n. 1, p. 16, doi. 10.1159/000109933
- By:
- Publication type:
- Article
5
Humanized Anti-CD25 Antibody Treatment with Daclizumab in Multiple Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2008, v. 5, n. 1, p. 23, doi. 10.1159/000109934
- By:
- Publication type:
- Article
6
Campath-1H Treatment of Multiple Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2008, v. 5, n. 1, p. 27, doi. 10.1159/000109935
- By:
- Publication type:
- Article
7
Positive and Negative Implications of Tumor Necrosis Factor Neutralization for the Pathogenesis of Multiple Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2008, v. 5, n. 1, p. 32, doi. 10.1159/000109936
- By:
- Publication type:
- Article
8
Preclinical Assessment of Therapeutic Antibodies against Human CD40 and Human Interleukin-12/23p40 in a Nonhuman Primate Model of Multiple Sclerosis.
- Published in:
- Neurodegenerative Diseases, 2008, v. 5, n. 1, p. 38, doi. 10.1159/000109937
- By:
- Publication type:
- Article
9
Author Index Vol. 5, No. 1, 2008.
- Published in:
- Neurodegenerative Diseases, 2008, v. 5, n. 1, p. 53, doi. 10.1159/000112546
- Publication type:
- Article
10
Subject Index Vol. 5, No. 1, 2008.
- Published in:
- Neurodegenerative Diseases, 2008, v. 5, n. 1, p. 54, doi. 10.1159/000112547
- Publication type:
- Article